医学
肠促胰岛素
兴奋剂
纤维化
内科学
活检
艾塞那肽
胃肠病学
泌尿科
2型糖尿病
糖尿病
内分泌学
受体
作者
Sudha S. Shankar,Samuel J. Daniels,Darren Robertson,Janeli Sarv,José Sánchez,Debra Carter,Lutz Jermutus,Benjamin Challis,Arun J. Sanyal
标识
DOI：10.1016/j.cgh.2024.04.017
摘要
Cotadutide, a peptide co-agonist at the glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptors, has demonstrated robust improvements in body weight, glycemia, and hepatic fat fraction (HFF) in patients living with obesity and type 2 diabetes mellitus.
科研通智能强力驱动
Strongly Powered by AbleSci AI
pluto
cdercder
Oracle
bc
qiao
笨笨芯
平常的毛豆
昏睡的蟠桃
研友_Y59785
小飞飞
wy.he
iNk
归尘
我剑也未尝不利
xiahou
余味
back you up
科研小民工
冰魂
高大凌寒
皖公网安备34019202002308
